Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06MNF
|
||||
| Former ID |
DCL000915
|
||||
| Drug Name |
Pardoprunox
|
||||
| Synonyms |
Pardoprunox (USAN/INN); 7-(4-methylpiperazin-1-yl)-3H-1,3-benzoxazol-2-one; 7-(4-methylpiperazin-1-yl)-3H-benzooxazol-2-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Advanced stage Parkinson's disease [ICD9: 332; ICD10:F02.3, G20] | Phase 2 | [536580] | ||
| Company |
Solvay
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C12H15N3O2
|
||||
| Canonical SMILES |
CN1CCN(CC1)C2=CC=CC3=C2OC(=O)N3
|
||||
| InChI |
1S/C12H15N3O2/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9/h2-4H,5-8H2,1H3,(H,13,16)
|
||||
| InChIKey |
YVPUUUDAZYFFQT-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 269718-84-5
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Agonist | [536580] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.